G.J. Creemers

Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial

Renu R. Bahadoer, Esmée A. Dijkstra, Boudewijn van Etten et al. · The Lancet Oncology · 2020 · 1.6K citations · Full text

Medicine, Oncology, Surgery +17

Chemotherapy, Bevacizumab, and Cetuximab in Metastatic Colorectal Cancer

Jolien Tol, Miriam Koopman, Annemieke Cats et al. · New England Journal of Medicine · 2009 · 1.4K citations · Full text

Medicine, Oncology, Pharmacology +16

The BRAF V600E mutation is an independent prognostic factor for survival in stage II and stage III colon cancer patients

Arantza Fariña Sarasqueta, Gesina van Lijnschoten, Elna Moerland et al. · Annals of Oncology · 2010 · 265 citations · Full text

Medicine, Molecular Genetics, Oncology +14

A randomised phase III study on capecitabine, oxaliplatin and bevacizumab with or without cetuximab in first-line advanced colorectal cancer, the CAIRO2 study of the Dutch Colorectal Cancer Group (DCCG). An interim analysis of toxicity

J. Tol, Miriam Koopman, C. J. Rodenburg et al. · Annals of Oncology · 2008 · 215 citations

Medicine, Oncology, Pharmacology +17

No improvement in median survival for patients with metastatic gastric cancer despite increased use of chemotherapy

Nienke Bernards, G.J. Creemers, Grard A. P. Nieuwenhuijzen et al. · Annals of Oncology · 2013 · 198 citations · Full text

Medicine, Oncology, Chemotherapy +12